Genpact (G) Stock Forecast, Price Target & Predictions
G Stock Forecast
Genpact stock forecast is as follows: an average price target of $41.67 (represents a 8.71% upside from G’s last price of $38.33) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
G Price Target
The average price target for Genpact (G) is $41.67 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $46.00 to $37.00. This represents a potential 8.71% upside from G's last price of $38.33.
G Analyst Ratings
According to 9 Wall Street analysts, Genpact's rating consensus is 'Hold'. The analyst rating breakdown for G stock is 0 'Strong Buy' (0.00%), 2 'Buy' (22.22%), 7 'Hold' (77.78%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Genpact Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 12, 2024 | Keith Bachman | BMO Capital | $42.00 | $36.84 | 14.01% | 9.57% |
| Jun 12, 2024 | Bryan Keane | Deutsche Bank | $37.00 | $32.67 | 13.25% | -3.47% |
| May 10, 2024 | Keith Bachman | BMO Capital | $38.00 | $34.38 | 10.53% | -0.86% |
| May 11, 2023 | Keith Bachman | Loop Capital Markets | $46.00 | $36.06 | 27.57% | 20.01% |
The latest Genpact stock forecast, released on Aug 12, 2024 by Keith Bachman from BMO Capital, set a price target of $42.00, which represents a 14.01% increase from the stock price at the time of the forecast ($36.84), and a 9.57% increase from G last price ($38.33).
Genpact Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 3 |
| Avg Price Target | $42.00 | $39.50 | $39.00 |
| Last Closing Price | $38.33 | $38.33 | $38.33 |
| Upside/Downside | 9.57% | 3.05% | 1.75% |
In the current month, the average price target of Genpact stock is $42.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 9.57% increase as opposed to Genpact's last price of $38.33. This month's average price target is up 6.33% compared to last quarter, and up 7.69% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 12, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Aug 09, 2024 | Needham | Buy | Buy | Hold |
| Aug 09, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Jul 17, 2024 | Wedbush | Market Perform | Market Perform | Hold |
| Jul 12, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jun 12, 2024 | Deutsche Bank | Hold | Hold | Hold |
| May 10, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| May 10, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Aug 09, 2023 | BMO Capital | Market Perform | Market Perform | Hold |
| Aug 09, 2023 | Jefferies | Hold | Hold | Hold |
Genpact's last stock rating was published by BMO Capital on Aug 12, 2024. The company gave G a "Market Perform" rating, the same as its previous rate.
Genpact Financial Forecast
Genpact Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.15B | $1.14B | $1.11B | $1.09B | $1.10B | $1.11B | - | $1.07B | $1.07B | $1.02B | $988.13M | $946.07M | $950.57M | $935.52M | $900.09M | $923.19M | $940.74M | $888.80M |
| Avg Forecast | $1.40B | $1.38B | $1.36B | $1.31B | $1.27B | $1.26B | $1.23B | $1.19B | $1.19B | $1.19B | $1.14B | $1.11B | $1.12B | $1.16B | $1.12B | $1.10B | $1.08B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| High Forecast | $1.41B | $1.39B | $1.37B | $1.31B | $1.28B | $1.26B | $1.24B | $1.20B | $1.20B | $1.19B | $1.15B | $1.12B | $1.13B | $1.20B | $1.12B | $1.11B | $1.09B | $1.10B | $1.07B | $1.03B | $1.04B | $1.02B | $966.89M | $926.32M | $936.32M | $905.62M | $840.37M | $896.20M | $913.67M | $881.75M |
| Low Forecast | $1.39B | $1.38B | $1.36B | $1.30B | $1.27B | $1.25B | $1.23B | $1.19B | $1.19B | $1.18B | $1.14B | $1.11B | $1.12B | $1.14B | $1.12B | $1.10B | $1.08B | $1.09B | $1.07B | $1.02B | $1.03B | $1.00B | $955.82M | $915.72M | $925.60M | $895.25M | $830.75M | $885.94M | $903.20M | $871.66M |
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 11 | 12 | 16 | 9 | 9 | 8 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.98% | 0.99% | 0.99% | 1.02% | 1.02% | - | 1.04% | 1.03% | 1.00% | 1.02% | 1.02% | 1.02% | 1.04% | 1.07% | 1.03% | 1.03% | 1.01% |
Genpact's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.11B, with a low forecast of $1.11B, and a high forecast of $1.12B. G's average Quarter revenue forecast represents a -3.17% decrease compared to the company's last Quarter revenue of $1.15B (Dec 23).
Genpact EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 11 | 12 | 16 | 9 | 9 | 8 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $162.73M | $165.69M | $185.71M | $173.16M | $131.53M | $184.38M | - | $165.73M | $153.05M | $178.99M | $191.23M | $178.87M | $153.17M | $165.37M | $134.26M | $163.76M | $161.80M | $154.46M |
| Avg Forecast | $213.08M | $210.59M | $207.89M | $199.26M | $193.80M | $191.51M | $188.31M | $181.66M | $182.22M | $180.77M | $174.45M | $184.67M | $171.08M | $176.44M | $170.55M | $167.88M | $165.25M | $155.87M | $163.72M | $152.62M | $156.46M | $141.70M | $149.66M | $142.36M | $146.92M | $141.75M | $69.50M | $134.65M | $158.91M | $142.58M |
| High Forecast | $214.31M | $211.81M | $209.10M | $200.41M | $194.92M | $192.61M | $189.40M | $182.72M | $183.28M | $181.82M | $175.46M | $221.60M | $172.60M | $182.41M | $171.54M | $201.45M | $166.20M | $187.04M | $163.72M | $183.14M | $187.75M | $170.04M | $179.59M | $170.84M | $176.30M | $170.10M | $83.40M | $161.58M | $190.69M | $171.10M |
| Low Forecast | $212.70M | $210.21M | $207.52M | $198.90M | $193.45M | $191.16M | $187.97M | $181.34M | $181.89M | $179.25M | $174.13M | $147.73M | $170.77M | $173.97M | $170.24M | $134.30M | $164.95M | $124.69M | $163.72M | $122.09M | $125.16M | $113.36M | $119.72M | $113.89M | $117.53M | $113.40M | $55.60M | $107.72M | $127.13M | $114.07M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.94% | 1.09% | 1.03% | 0.80% | 1.18% | - | 1.09% | 0.98% | 1.26% | 1.28% | 1.26% | 1.04% | 1.17% | 1.93% | 1.22% | 1.02% | 1.08% |
3 analysts predict G's average Quarter EBITDA for Mar 24 to be $184.67M, with a high of $221.60M and a low of $147.73M. This is 13.48% upper than Genpact's previous annual EBITDA (Dec 23) of $162.73M.
Genpact Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 11 | 12 | 16 | 9 | 9 | 8 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $291.31M | $117.59M | $116.25M | $106.10M | $89.71M | $95.84M | - | $96.18M | $73.08M | $102.39M | $102.70M | $91.27M | $74.98M | $85.44M | $62.16M | $85.70M | $82.20M | $88.12M |
| Avg Forecast | $189.96M | $186.34M | $179.10M | $135.68M | $164.63M | $158.30M | $153.10M | $133.65M | $151.77M | $145.59M | $130.61M | $101.01M | $133.24M | $134.67M | $124.27M | $91.82M | $123.17M | $89.16M | $117.67M | $83.48M | $74.71M | $81.06M | $80.38M | $72.65M | $71.92M | $73.23M | $32.18M | $70.46M | $80.73M | $81.34M |
| High Forecast | $191.39M | $187.74M | $180.45M | $136.70M | $165.87M | $159.49M | $154.25M | $134.65M | $152.91M | $149.23M | $131.59M | $121.21M | $144.04M | $138.31M | $125.21M | $110.19M | $124.10M | $106.99M | $117.67M | $100.17M | $89.65M | $97.27M | $96.45M | $87.18M | $86.31M | $87.88M | $38.61M | $84.56M | $96.88M | $97.61M |
| Low Forecast | $189.51M | $185.90M | $178.68M | $135.37M | $164.24M | $157.93M | $152.74M | $133.34M | $151.41M | $141.95M | $130.30M | $80.80M | $129.64M | $131.03M | $123.98M | $73.46M | $122.88M | $71.33M | $117.67M | $66.78M | $59.77M | $64.84M | $64.30M | $58.12M | $57.54M | $58.58M | $25.74M | $56.37M | $64.58M | $65.07M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.19% | 0.87% | 0.94% | 1.16% | 0.73% | 1.07% | - | 1.15% | 0.98% | 1.26% | 1.28% | 1.26% | 1.04% | 1.17% | 1.93% | 1.22% | 1.02% | 1.08% |
Genpact's average Quarter net income forecast for Mar 24 is $101.01M, with a range of $80.80M to $121.21M. G's average Quarter net income forecast represents a -65.33% decrease compared to the company's last Quarter net income of $291.31M (Dec 23).
Genpact SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 11 | 12 | 16 | 9 | 9 | 8 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $237.42M | $229.73M | $229.43M | $216.49M | $236.56M | $231.44M | - | $237.30M | $244.86M | $215.96M | $204.17M | $200.73M | $207.86M | $198.34M | $183.27M | $194.38M | $210.05M | $192.00M |
| Avg Forecast | $299.68M | $296.18M | $292.39M | $280.24M | $272.56M | $269.34M | $264.84M | $255.50M | $256.28M | $254.24M | $245.34M | $249.21M | $240.60M | $248.15M | $239.86M | $226.55M | $232.40M | $188.06M | $230.26M | $205.96M | $250.30M | $170.97M | $159.78M | $159.77M | $199.38M | $170.00M | $94.87M | $159.82M | $206.30M | $177.23M |
| High Forecast | $301.41M | $297.90M | $294.08M | $281.87M | $274.14M | $270.90M | $266.37M | $256.97M | $257.76M | $255.71M | $246.76M | $299.05M | $242.75M | $256.54M | $241.25M | $271.86M | $233.75M | $225.68M | $230.26M | $247.15M | $300.36M | $205.16M | $191.74M | $191.72M | $239.25M | $204.00M | $113.84M | $191.78M | $247.55M | $212.68M |
| Low Forecast | $299.14M | $295.65M | $291.86M | $279.74M | $272.07M | $268.85M | $264.36M | $255.03M | $255.82M | $252.10M | $244.90M | $199.36M | $240.17M | $244.67M | $239.43M | $181.24M | $231.98M | $150.45M | $230.26M | $164.76M | $200.24M | $136.77M | $127.83M | $127.81M | $159.50M | $136.00M | $75.90M | $127.86M | $165.04M | $141.79M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.93% | 0.96% | 0.96% | 1.02% | 1.23% | - | 1.15% | 0.98% | 1.26% | 1.28% | 1.26% | 1.04% | 1.17% | 1.93% | 1.22% | 1.02% | 1.08% |
Genpact's average Quarter SG&A projection for Mar 24 is $249.21M, based on 3 Wall Street analysts, with a range of $199.36M to $299.05M. The forecast indicates a 4.96% rise compared to G last annual SG&A of $237.42M (Dec 23).
Genpact EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 11 | 12 | 16 | 9 | 9 | 8 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.59 | $0.65 | $0.63 | $0.58 | $0.49 | $0.52 | - | $0.52 | $0.39 | $0.55 | $0.55 | $0.48 | $0.40 | $0.45 | $0.33 | $0.45 | $0.43 | $0.46 |
| Avg Forecast | $1.05 | $1.03 | $0.99 | $0.75 | $0.91 | $0.88 | $0.85 | $0.74 | $0.84 | $0.80 | $0.72 | $0.68 | $0.74 | $0.74 | $0.69 | $0.65 | $0.68 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| High Forecast | $1.06 | $1.04 | $1.00 | $0.76 | $0.92 | $0.88 | $0.85 | $0.74 | $0.85 | $0.82 | $0.73 | $0.69 | $0.80 | $0.76 | $0.69 | $0.65 | $0.69 | $0.71 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.49 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| Low Forecast | $1.05 | $1.03 | $0.99 | $0.75 | $0.91 | $0.87 | $0.84 | $0.74 | $0.84 | $0.78 | $0.72 | $0.68 | $0.72 | $0.72 | $0.69 | $0.65 | $0.68 | $0.70 | $0.65 | $0.52 | $0.52 | $0.56 | $0.53 | $0.48 | $0.48 | $0.49 | $0.34 | $0.45 | $0.55 | $0.51 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.16% | 0.87% | 0.92% | 0.89% | 0.72% | 0.74% | - | 0.99% | 0.75% | 0.98% | 1.02% | 0.99% | 0.82% | 0.91% | 0.96% | 1.00% | 0.77% | 0.88% |
According to 3 Wall Street analysts, Genpact's projected average Quarter EPS for Mar 24 is $0.68, with a low estimate of $0.68 and a high estimate of $0.69. This represents a -57.16% decrease compared to G previous annual EPS of $1.59 (Dec 23).
Genpact Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TTEC | TTEC | $4.45 | $35.67 | 701.57% | Buy |
| TWKS | Thoughtworks | $4.38 | $13.63 | 211.19% | Hold |
| CLVT | Clarivate | $6.67 | $14.33 | 114.84% | Buy |
| WNS | WNS | $56.89 | $87.17 | 53.23% | Buy |
| JKHY | Jack Henry & Associates | $169.64 | $191.60 | 12.95% | Buy |
| ASGN | ASGN | $89.74 | $100.25 | 11.71% | Hold |
| G | Genpact | $38.33 | $41.67 | 8.71% | Hold |
| CDW | CDW | $212.21 | $229.75 | 8.27% | Buy |
| PRFT | Perficient | $75.21 | $81.00 | 7.70% | Hold |
| CACI | CACI | $466.73 | $447.50 | -4.12% | Buy |
| SAIC | Science Applications | $133.15 | $123.00 | -7.62% | Buy |
| BR | Broadridge Financial Solutions | $207.59 | $176.00 | -15.22% | Buy |
| EXLS | ExlService | $35.49 | $23.10 | -34.91% | Buy |
G Forecast FAQ
Is Genpact a good buy?
No, according to 9 Wall Street analysts, Genpact (G) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 22.22% of G's total ratings.
What is G's price target?
Genpact (G) average price target is $41.67 with a range of $37 to $46, implying a 8.71% from its last price of $38.33. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Genpact stock go up soon?
According to Wall Street analysts' prediction for G stock, the company can go up by 8.71% (from the last price of $38.33 to the average price target of $41.67), up by 20.01% based on the highest stock price target, and down by -3.47% based on the lowest stock price target.
Can Genpact stock reach $60?
G's average twelve months analyst stock price target of $41.67 does not support the claim that Genpact can reach $60 in the near future.
What is Genpact's current price target trend?
1 Wall Street analyst forecast a $42 price target for Genpact (G) this month, up 9.57% from its last price of $38.33. Compared to the last 3 and 12 months, the average price target increased by 3.05% and increased by 1.75%, respectively.
What are Genpact's analysts' financial forecasts?
Genpact's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.95B (high $4.98B, low $4.94B), average EBITDA is $755.27M (high $759.64M, low $753.91M), average net income is $609.67M (high $614.26M, low $608.24M), average SG&A $1.06B (high $1.07B, low $1.06B), and average EPS is $3.37 (high $3.4, low $3.36). G's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $5.45B (high $5.48B, low $5.44B), average EBITDA is $830.83M (high $835.64M, low $829.33M), average net income is $691.08M (high $696.28M, low $689.46M), average SG&A $1.17B (high $1.18B, low $1.17B), and average EPS is $3.82 (high $3.85, low $3.81).
Did the G's actual financial results beat the analysts' financial forecasts?
Based on Genpact's last annual report (Dec 2023), the company's revenue was $4.48B, which missed the average analysts forecast of $4.5B by -0.43%. Apple's EBITDA was $630.86M, missing the average prediction of $685.94M by -8.03%. The company's net income was $631.26M, beating the average estimation of $484.01M by 30.42%. Apple's SG&A was $913.06M, missing the average forecast of $955.17M by -4.41%. Lastly, the company's EPS was $3.41, beating the average prediction of $2.82 by 21.07%. In terms of the last quarterly report (Dec 2023), Genpact's revenue was $1.15B, beating the average analysts' forecast of $1.12B by 2.20%. The company's EBITDA was $162.73M, missing the average prediction of $171.08M by -4.88%. Genpact's net income was $291.31M, beating the average estimation of $133.24M by 118.64%. The company's SG&A was $237.42M, missing the average forecast of $240.6M by -1.32%. Lastly, the company's EPS was $1.59, beating the average prediction of $0.736 by 115.89%